Interleukin-10 secretion pathway

The "Interleukin‑10 secretion pathway" is not a single molecule or receptor but rather refers to the network of molecular events and regulatory mechanisms that control the production and release of interleukin‑10 (IL‑10), an anti-inflammatory cytokine. This pathway involves multiple cell types—including monocytes, macrophages, T cells, B cells, NK cells, and others—that can secrete IL‑10 in response to various stimuli such as microbial products or other cytokines[1][5]. The regulation of this process occurs at both transcriptional and post-transcriptional levels through promoter elements, chromatin remodeling, microRNAs, and feedback loops involving other cytokines like TNF-alpha and IL‑12[1][3][5]. Genetic variation in the *IL10* gene locus influences individual differences in IL‑10 production[3]. The secreted IL‑10 then acts via its specific receptor complex to activate downstream anti-inflammatory signaling pathways such as JAK/STAT3[2][4]. **Note:** This entry is marked as incorrect for a canonical target because "Interleukin‑10 secretion pathway" describes a biological process rather than a discrete druggable entity like a protein or receptor. For structured data on therapeutic targets related to this system, refer instead to "Interleukin 10" (IL‑10) itself or its receptor components ("Interleukin 10 receptor alpha", "Interleukin 10 receptor beta")[1][2][6].

Other names

IL-10 signaling pathwayIL-10 pathwayInterleukin-10 signaling cascade